Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric IgG monoclonal antibody cG250

EU orphan designation number: EU/3/02/094   
Active ingredient: Chimeric IgG monoclonal antibody cG250
Indication: Treatment of renal cell carcinoma
Sponsor: Wilex AG
Grillparzerstraße 10, D-81675 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/03/2002 Centralised Orphan - Designation EMEA/OD/052/01 (2002)1230 of 19/03/2002
01/09/2006 Other procedure